Long-Term Outcome in Congenital Undescended Testis After Surgical Treatment by Orchidopexy

The purpose of this study is to determine the long-term outcome in congenital undescended testis after surgical treatment by orchidopexy and to what extent orchidopexy is the treatment for congenital undescended testis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Undescended Testis Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Cryptorchidism Endocrine System Diseases Genital Diseases Genital Diseases, Male Gonadal Disorders Male Urogenital Diseases Testicular Diseases Urogenital Abnormalities Urogenital Diseases

Age range

6 month–25 year

Sex eligibility

Male

Study type

Observational

Primary location

Medical Center Alkmaar

Alkmaar, North Holland, 1815 J D, Netherlands

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

The orchidopexy has taken place in the Medical Center Alkmaar between 1986-2004
The indication concerned a congenital undescended testis
It concerns a first orchidopexy to the concerning testis

Exclusion criteria

Orchidopexy has taken place on an other reason than congenital undescended testis (for example: torsio testis)
It concerns re-orchidopexy

Sponsors and collaborators

Lead sponsor

Medical Center Alkmaar

Other

Registry information

Important dates

Study start: 2006
Study completion: 2007
First posted: Nov 15, 2005
Registry last updated: May 22, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed